Perimenopause, the transition women go through prior to menopause, causes abnormal periods, erratic fluctuations in hormone levels, insomnia and, for many women, unpleasant hot flashes. Did you know you're two-to-four-times more likely to suffer from depression during the menopause transition?
A new study suggests that transdermal estradiol could be the key to not only treating existing perimenopausal depression, but also possibly preventing it, and the chances that it will benefit your mood are greater the more stress you're under. The study results will be presented during The North American Menopause Society (NAMS) Annual Meeting in Philadelphia, October 11-14, 2017.
Vaginal Estrogen Safe in Treating Menopause Symptoms
Safety of vaginal estrogen in treating menopause symptoms allows women to make informed decisions regarding their treatment options.
Advertisement
‘Depression is a commonly reported symptom of the menopause transition. Women with the greatest frequency of hot flashes reported the most significant depressive symptoms.’
Tweet it Now
It's no secret that depression is a commonly reported symptom of the menopause transition. Several small trials have previously suggested that transdermal estradiol therapy (i.e., an estrogen patch) effectively treats perimenopausal depression. But this is the first study to examine its effectiveness in preventing the onset of perimenopausal depression among women who were previously not depressed. Estradiol is the primary estrogen (female sex hormone) that is produced during a woman's reproductive years, impacting reproduction as well as sexual function.
A 12-month intervention conducted by Drs. David Rubinow and Susan Girdler and their team at the University of North Carolina at Chapel Hill demonstrated that transdermal estradiol was more effective than placebo in maintaining a more positive mood and in preventing the emergence of clinically significant depression particularly among women in the early menopause transition (as opposed to women in the late menopause transition or postmenopausal period). The effectiveness of treatment on mood was also stronger in women who reported a greater number of stressful events in the six months preceding enrollment.
![The Relationship Between Menopause, Regular Physical Activity and Cardiovascular Ageing]( "The Relationship Between Menopause, Regular Physical Activity and Cardiovascular Ageing")
Turns out, for women, blood vessel health and the effect of exercise may be related more to menopausal status than fitness.
"This study suggests that the stabilization of fluctuating estradiol levels, which are characteristic of the menopause transition, with transdermal estradiol may represent one option for preventing the development of depressive symptoms in the menopause transition," says Dr. Jennifer Gordon, a lead researcher on the study team from the University of Regina in Saskatchewan, Canada.
"An interesting finding in this study is the impact of recent life events, which signals that healthcare providers may need to inquire about such events when determining whether or not to prescribe transdermal estradiol to influence mood in perimenopausal women experiencing depressive symptoms," says Dr. JoAnn Pinkerton, NAMS executive director."
Drs. Gordon and Pinkerton are available for interviews before the presentation at the Annual Meeting.
Source: Eurekalert
The Relationship Between Menopause, Regular Physical Activity and Cardiovascular Ageing
Turns out, for women, blood vessel health and the effect of exercise may be related more to menopausal status than fitness.
Advertisement
"This study suggests that the stabilization of fluctuating estradiol levels, which are characteristic of the menopause transition, with transdermal estradiol may represent one option for preventing the development of depressive symptoms in the menopause transition," says Dr. Jennifer Gordon, a lead researcher on the study team from the University of Regina in Saskatchewan, Canada.
"An interesting finding in this study is the impact of recent life events, which signals that healthcare providers may need to inquire about such events when determining whether or not to prescribe transdermal estradiol to influence mood in perimenopausal women experiencing depressive symptoms," says Dr. JoAnn Pinkerton, NAMS executive director."
Drs. Gordon and Pinkerton are available for interviews before the presentation at the Annual Meeting.
Source: Eurekalert
Obesity and Glucose Intolerance During Menopause Prevented by Estrogen in the Brain
Adding estrogen in the brain may improve health in obese females after menopause,has been found by researchers at the University of Cincinnati (UC).
Advertisement
 Menopause May Help Provide an Evolutionary AdvantageMenopause and long post-reproductive lifespan provide an evolutionary advantage; that is, they increase the chances of a woman passing on her genes. | Advertisement
|
Advertisement
Recommended Reading
Latest Women Health News
A new study investigated the rate of neural tube defects in predominantly Hispanic-populated women before and after the voluntary fortification of corn masa flour with folic acid.
Experts suggest that getting regular mammograms at the age of 40 can help women prevent breast cancer.
The commonly used Fracture Risk Assessment Tool (FRAX) is not useful for shared clinical decision-making regarding osteoporosis screening in younger postmenopausal women.
Researchers hypothesized that adverse pregnancy outcomes (APO) are associated with younger age at first stroke, with a stronger relationship in those with >1 pregnancy with APO.
Women grapple with the risk of mental illnesses as immense challenge of constantly striving for perfection and balancing multiple roles takes a toll.